Polymed Therapeutics, Inc., a subsidiary of Athenex, Inc., is a leading global manufacturer and distributor of active pharmaceutical ingredients (cGMP API), specialized in oncology APIs. We have been operating for over 20 years.
Having developed our proprietary APIs, we implement state-of-the-art manufacturing in our cGMP facility to produce highest-quality products, meeting the most recent regulatory, cGMP standards, and IP requirements for regulated markets.
Our cGMP manufacturing facility has been repeatedly inspected and certified by USFDA, France ANSM, Japan PMDA, and China NMPA. With USDMFs, CEPs, ASMFs, Canada DMFs and Australian DMFs for various products.
Our Fine Chemicals division specializes in Custom Synthesis, and serves the global markets of Pharmaceutical and Specialty Chemicals. Our team of scientists is experienced in the whole range of manufacturing – from R&D, pilot scale, to industrial scale. Being flexible and fast, our plants achieve extremely complex or simple synthesis, for large or small demands.
Polymed Therapeutics is technologically proficient and dedicated to providing the high-quality products and services at competitive costs, to be the optimal strategic API supplier.